Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials

12Citations
Citations of this article
85Readers
Mendeley users who have this article in their library.

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by protein aggregation in the brain. Recent studies have revealed the critical role of microglia in AD pathogenesis. This review provides a comprehensive summary of the current understanding of microglial involvement in AD, focusing on genetic determinants, phenotypic state, phagocytic capacity, neuroinflammatory response, and impact on synaptic plasticity and neuronal regulation. Furthermore, recent developments in drug discovery targeting microglia in AD are reviewed, highlighting potential avenues for therapeutic intervention. This review emphasizes the essential role of microglia in AD and provides insights into potential treatments.

Cite

CITATION STYLE

APA

Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., … Lan, J. (2023). Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials. Frontiers in Aging Neuroscience. Frontiers Media SA. https://doi.org/10.3389/fnagi.2023.1201982

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free